EGPO
TAK icon

EnTrust Global Partners Offshore’s Takeda Pharmaceutical TAK Stock Holding History

EnTrust Global Partners Offshore’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-61,100
Closed -$1.03M – 75
2018
Q4 		$1.03M Buy
+61,100
New +$1.03M 0.73% 27

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

EnTrust Global Partners Offshore's TAK Position: Q1 2019 in Review

EnTrust Global Partners Offshore sold out of Takeda Pharmaceutical (TAK) in Q1 2019, closing a stake of 61,100 shares — an estimated $1.03M sold.

EnTrust Global Partners Offshore first reported a position in TAK in Q4 2018 and held it in 1 quarter. The position peaked at $1.03M in Q4 2018. 390 funds tracked by Wall St. Rank hold TAK as of Q1 2019.

  • EnTrust Global Partners Offshore reported no remaining Takeda Pharmaceutical position as of Q1 2019 after selling out during the quarter.
  • EnTrust Global Partners Offshore sold 61,100 Takeda Pharmaceutical shares in Q1 2019, an estimated $1.03M.
  • EnTrust Global Partners Offshore first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 1 quarter.
  • EnTrust Global Partners Offshore's Takeda Pharmaceutical position peaked at $1.03M in Q4 2018.
  • 390 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2019.

Based on EnTrust Global Partners Offshore's 13F filing for Q1 2019, filed 15 May 2019.